Cargando…

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker

Background: N(6)-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) has been identified as a member of m6A reader protein involving in many vital biological processes, whereas i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Weiwei, Liu, Chaoqun, You, Jia, Chen, Zilin, Qian, Cheng, Lin, Wandie, Yu, Lina, Ye, Lele, Zhao, Liang, Zhou, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470763/ https://www.ncbi.nlm.nih.gov/pubmed/36120577 http://dx.doi.org/10.3389/fcell.2022.954214

Ejemplares similares

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

YTHDF2 Regulates Maternal Transcriptome Degradation and Embryo Development in Goat
por: Deng, Mingtian, et al.
Publicado: (2020)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
por: Jia, Zeming, et al.
Publicado: (2022)

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
por: Zhao, Qi, et al.
Publicado: (2021)

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
por: Wu, Gujie, et al.
Publicado: (2022)

The m(6)A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m(6)A-Dependent Manner
por: Chen, Xiao-Yu, et al.
Publicado: (2021)

The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021)

ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Huang, Shenglan, et al.
Publicado: (2022)

Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer
por: Zhang, Lingyun, et al.
Publicado: (2022)

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
por: Yuan, Jing, et al.
Publicado: (2022)

Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer
por: Shi, Zhi-Zhou, et al.
Publicado: (2021)

Integrated Analysis of Immune Infiltration Features for Cervical Carcinoma and Their Associated Immunotherapeutic Responses
por: Kang, Yanan, et al.
Publicado: (2021)

Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer
por: Hong, Kai, et al.
Publicado: (2022)

LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer
por: Song, Yang, et al.
Publicado: (2021)

Characterization of lncRNA-Perturbed TLR-Signaling Network Identifies Novel lncRNA Prognostic Biomarkers in Colorectal Cancer
por: Chu, Yanjie, et al.
Publicado: (2020)

Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis
por: Zhang, Chiyuan, et al.
Publicado: (2021)

N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
por: Zhan, Lei, et al.
Publicado: (2021)

Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines
por: Ding, ShiJian, et al.
Publicado: (2021)

Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers
por: Zhao, Ning, et al.
Publicado: (2022)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types
por: Liu, Taisheng, et al.
Publicado: (2022)

Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
por: Shen, Liping, et al.
Publicado: (2023)

The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis
por: Song, Na, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

Comprehensive analysis of REST corepressors (RCORs) in pan-cancer
por: Zheng, Rong, et al.
Publicado: (2023)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
por: Abdelatty, Alaa, et al.
Publicado: (2022)

Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment
por: Xu, Fangfang, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
por: Jiang, Xiulin, et al.
Publicado: (2021)

The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer
por: Tang, Xudong, et al.
Publicado: (2021)

Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis
por: Liu, Ting-Ting, et al.
Publicado: (2021)

Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis
por: Jiang, Xiulin, et al.
Publicado: (2022)

Identifying Protein Biomarkers in Blood for Alzheimer's Disease
por: Zhao, Tianyi, et al.
Publicado: (2020)

A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma
por: Cai, Xiaomin, et al.
Publicado: (2021)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

SNHG10 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Prostate Cancer
por: Chen, Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqqcecqriq5gv4ris7itc7nfoc